Myositis in the course of the systemic form juvenile idiopathic arthritis
The systemic juvenile idiopathic arthritis (SJIA) represents approximately 10% of all cases of JIA, there is no difference in onset rate between boys and girls. SJIA is characterized by pain of the joints, high, remitting fever, polymorphous skin rash and symptoms in other organs. Hepatosplenomega...
Main Authors: | Piotr Gietka, Lidia Rutkowska-Sak, Barbara Lisowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2014-06-01
|
Series: | Rheumatology |
Subjects: | |
Online Access: | http://www.termedia.pl/Myositis-in-the-course-of-the-systemic-form-juvenile-idiopathic-arthritis,18,22772,1,1.html |
Similar Items
-
CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-09-01) -
CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS
by: E. I. Alexeeva, et al.
Published: (2014-03-01) -
IL-1 inhibition in systemic juvenile idiopathic arthritis
by: Gabriella Giancane, et al.
Published: (2016-12-01) -
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
by: Toplak N, et al.
Published: (2018-06-01) -
Experience of the Successful Treatment With Canakinumab of a Patient With Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)